AbbVie Inc
ABBV
|
|
| |
|
| Trading Volume | 137,962 |
|
|
197.40 - 137.61 |
| Market Cap Full | $ 344.7B |
Quarterly +
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Q1 | 1.9% | 17.5% | -1.5% | 20.8% |
| Q2 | - | -6.2% | -15.5% | -6.3% |
| Q3 | - | 5.4% | 10.7% | -13.3% |
| Q4 | - | 0.7% | 4.6% | 21.7% |
Monthly +
| J | F | M | A | M | J | J | A | S | O | N | D |
| 2025 | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1.9 | - | - | - | - | - | - | - | - | - | - | - |
| 2024 | |||||||||||
| 6 | 6.8 | 3.7 | -7.6 | -4.5 | 5.4 | 9.4 | 5.4 | - | - | - | - |
| 2023 | |||||||||||
| -8.6 | 4.1 | 3.6 | -5.2 | -8.7 | -2.4 | 11.1 | -1.8 | 1.5 | -5.3 | 0.8 | 8.9 |
| 2022 | |||||||||||
| 0.4 | 8 | 11.4 | -10.2 | 0.3 | 3.9 | -6.3 | -6.3 | -1.2 | 10.2 | 10.1 | 0.3 |
| 2021 | |||||||||||
| -3.7 | 5.1 | 0.5 | 3.1 | 1.5 | -0.5 | 3.3 | 3.9 | -10.7 | 6.3 | 1.3 | 16.5 |
| 2020 | |||||||||||
| -8.5 | 1 | -6.9 | 7.9 | 12.7 | 6 | -3.3 | 0.9 | -8.2 | -3.3 | 22.9 | 1.7 |
EPS
| 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|
| Q1 | 0.1 | 2.5 | 2 | 2 |
| Q2 | 1.1 | 0.5 | 0.4 | -0.5 |
| Q3 | 1 | 2.2 | 1.8 | 1.3 |
| Q4 | 0 | 1.4 | 2.3 | 0 |
| A | 2.27 | 6.6 | 6.5 | 2.7 |